Carbon Silicon
Venture capitalActively deployingCarson City · Pre-Seed–Series A · 1 people tracked
Investment thesis
Carbon Silicon Ventures backs founders transforming biology into an engineering discipline. Its portfolio centers on tools, platforms, and infrastructure at the intersection of biology, engineering, and AI—including DNA synthesis, drug discovery, bioinformatics and genomic data infrastructure, lab automation, microfluidics, physical AI for biological data collection, surgical robotics, phage-drug conjugates, and AI-designed protein ingredients for food. The firm favors deeptech and biotech companies building the underlying engineering layers that make biology programmable, automatable, and scalable.
Source: firm website, verified Aug 25, 2026.
Team · 1 people
from public directories
What they invest in
from 10 of 11 portfolio companiesBiotech ×8Deep Tech ×6AI & Machine Learning ×5Healthtech ×3Medical Devices ×2Robotics ×2Cloud Computing ×1Data & Infrastructure ×1
HQs:United States×5
Investments · 11 tracked
founders shown can be your intro path
Ansa provides an enzymatic DNA synthesis platform that directly synthesizes complex sequences up to 900 bp and delivers constructs up to 50 kb without assembly-based methods.
BiotechDeep TechHealthtechEmeryville, US
Dan Lin-Arlow(Founder)inSebastian Palluk(Founder)inDaniel Lin-Arlow(Executive Officer, Director)Daniel Hillel Lin-Arlow(Executive Officer, Director)Jason T. Gammack(Executive Officer, Director)
BoardYanniv Dorone(Director)
PartnerNish Bhat· solo GP
Co-investorsDauntless VenturesFifty YearsMetaplanetY CombinatorFall Line CapitalHorizons Ventures+2 more
Basepair is a SaaS bioinformatics platform that provisions in a customer's own AWS account to store and analyze genomic and next-generation sequencing (NGS) data without moving it, offering point-and-click and API-driven workflows plus interactive visualization.
BiotechCloud ComputingData & InfrastructureNew York, US
AMIT SINHA(Executive Officer, Director)Amit Sinha(CEO & Founder)Amit U Sinha(Founder)in
PartnerNish Bhat· solo GP
Co-investorsDraper AssociatesEntrepreneurs Roundtable Accelerator (ERA)Fresco CapitalMetaplanet37 Angels
Bluenote provides an AI platform for life sciences companies that automates the drafting of scientific and regulatory documents, workflow automation, and internal data search to speed up regulatory submissions.
AI & Machine LearningEnterprise SoftwareHealthtech
Fatima Sabar(Founder)in
PartnerNish Bhat· solo GP
Co-investorsElectric CapitalLux CapitalMcKesson VenturesMoxxie Ventures
Current Surgical develops a smart needle technology platform for surgical treatment of cancerous tumors.
Deep TechHealthtechMedical DevicesWashington, US
PartnerNish Bhat· solo GP
Co-investorsTrue VenturesDraper AssociatesSciFounders
FemtoFluidics is an early-stage company positioning around drug discovery, with a tagline referencing applying Moore's Law-style scaling to the field.
AI & Machine LearningBiotechDeep Tech
PartnerNish Bhat· solo GP
Medra builds robotic systems integrated with AI, computer vision, and natural language processing to automate data collection for life science research.
AI & Machine LearningBiotechDeep TechRobotics
Michelle Lee(Co-founder)in
PartnerNish Bhat· solo GP
Co-investorsFifty YearsFusionHuman CapitalLux CapitalMenlo VenturesMetaplanet+4 more
Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases.
AI & Machine LearningBiotechDeep TechMedical DevicesEmeryville, US
Sri Kosuri(Co-founder)inRamsey Homsany(Founder)in
PartnerNish Bhat· solo GP
Co-investorsAndreessen Horowitz+ND Capital8VCCatalio Capital Management, LPFifty YearsFlucas Ventures+5 more
Paralos is developing a modular M13 phage drug delivery platform that creates phage-drug conjugates to concentrate therapeutic payloads at specific targets.
BiotechDeep Tech
PartnerNish Bhat· solo GP
Tetsuwan operates a cloud lab and automation platform called ResearchOS that lets researchers configure, simulate, and run biology experiments from their browser without physical lab access.
AI & Machine LearningBiotechRoboticsNew York, US
Cristian Ponce(CEO)inThéo Schäfer(Cofounder)in
PartnerNish Bhat· solo GP
Co-investors2048 VenturesEntrepreneur First
Tomorrow is an ingredient design studio that combines the 20 natural amino acids to create engineered proteins (Tomorrow Taste Proteins™) that produce specific tastes, including a sugar-substitute called TomorrowSweet™.
BiotechFoodTechNew Materials
PartnerNish Bhat· solo GP
Portfolio news
latest coverage across their companiesMedra · hlth.com · Dec 15, 2025
Octant Bio · salestools.io · Oct 23, 2025
Ansa Biotechnologies · drugdiscoverynews.com · Oct 9, 2025
Frequently asked questions
- How many investments has Carbon Silicon made?
- Carbon Silicon has 11 tracked investments.
- What stage does Carbon Silicon invest at?
- Carbon Silicon invests at the Pre-Seed, Seed, Series A stages.
- What is Carbon Silicon's typical check size?
- Carbon Silicon typically writes checks of $100K – $500K.
- What sectors does Carbon Silicon focus on?
- Carbon Silicon focuses on AI & Machine Learning, Biotech, Data & Infrastructure, Deep Tech, FoodTech, Healthtech, Longevity.
- Where is Carbon Silicon located?
- Carbon Silicon is headquartered in Carson City, US.
- Does Carbon Silicon lead rounds?
- Carbon Silicon typically participates in rounds rather than leading them.
- Who does Carbon Silicon co-invest with?
- Carbon Silicon most often shares deals with Metaplanet, Fifty Years, Draper Associates, among 26 tracked co-investors.
Images
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.
Unruly Capital is a venture firm that backs founders working on ideas that seem too early or unconventional but are expected to become mainstream within a decade, focusing on frontier technology themes.